Tech Company Financing Transactions

Advanced Biohealing Funding Round

Advanced Biohealing closed a $8 million Series B funding round on 11/21/2005. Investors included Canaan Partners and Wheatley Partners.

Transaction Overview

Announced On
11/21/2005
Transaction Type
Venture Equity
Amount
$8,000,000
Round
Series B
Investors

Canaan Partners (Steven Bloch)

Wheatley Partners (David Dantzker)

Proceeds Purpose
David Eisenbud, MD, President & CEO of Advanced BioHealing said, "The Series B funds will finance ABH's pivotal clinical trial to study Celaderm� for accelerating healing in partial-thickness burns, enable manufacturing scale-up and develop a marketing team. We are fortunate to be able to draw upon the extensive life-science networks and experience of our venture capital co-lead investors, Canaan Partners and Wheatley Partners."

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
36 Church Ln.
Westport, CT 06880
USA
Email Address
Overview
Advanced BioHealing (ABH) is a specialty biotechnology company focused on the development and marketing of cell-based and tissue-engineered products for wound care. We are a privately held company with two approved products: Dermagraft and TransCyte.
Profile
Advanced Biohealing LinkedIn Company Profile
Social Media
Advanced Biohealing Company Twitter Account
Company News
Advanced Biohealing News
Facebook
Advanced Biohealing on Facebook
YouTube
Advanced Biohealing on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Kevin Rakin
  Kevin Rakin LinkedIn Profile  Kevin Rakin Twitter Account  Kevin Rakin News  Kevin Rakin on Facebook
Chief Medical Officer
Jan Lessem
  Jan Lessem LinkedIn Profile  Jan Lessem Twitter Account  Jan Lessem News  Jan Lessem on Facebook
Chief Scientific Officer
Charles Hart
  Charles Hart LinkedIn Profile  Charles Hart Twitter Account  Charles Hart News  Charles Hart on Facebook
Controller
Marc Posel
  Marc Posel LinkedIn Profile  Marc Posel Twitter Account  Marc Posel News  Marc Posel on Facebook
Vice President
Therésa Dixon
  Therésa Dixon LinkedIn Profile  Therésa Dixon Twitter Account  Therésa Dixon News  Therésa Dixon on Facebook
Vice President
Dean Tozer
  Dean Tozer LinkedIn Profile  Dean Tozer Twitter Account  Dean Tozer News  Dean Tozer on Facebook
VP - Operations
Kathy McGee
  Kathy McGee LinkedIn Profile  Kathy McGee Twitter Account  Kathy McGee News  Kathy McGee on Facebook
VP - Sales
Keith O'Briant
  Keith O'Briant LinkedIn Profile  Keith O'Briant Twitter Account  Keith O'Briant News  Keith O'Briant on Facebook


 

 

Browse more venture capital transactions:

Prev: 11/18/2005: BroadLight venture capital transaction
Next: 11/22/2005: Brightcove venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary